JCV is a DNA polyomavirus and the primary aetiological agent of PML. Most adults carry JCV in its latent form, but the virus ...

The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

Draft amendments to the Drugs Rules would remove duplicate viral tests on finished plasma-derived medicines once source plasma is verified as safe, aimed at accelerating production of critical ...

The boss of Yorkshire-based lateral flow test developer Abingdon Health has said the company is still benefiting after the pandemic turned a once rarely discussed product into a household name.

Joe Reader is running the London Marathon to raise awareness for Coeliac UK and help fund crucial research which could lead to more diagnoses.

Dung beetles are paralysed by excessive wormer use, and overscrupulous poo-picking is bad for their habitats ...

Up to 30% of children with juvenile arthritis develop uveitis, an eye inflammation that can damage vision. New research highlights immune cells as treatment targets.

After a strong start to the year, the value of biotech financings has tailed off a little, but March has seen a clutch of $50 ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark approval for its Elecsys® Apolipoprotein E4 ...